Literature DB >> 10420116

Cataract development in 12-month-old rats fed a 25% galactose diet and its relation to osmotic stress and oxidative damage.

Y Ohta1, T Yamasaki, T Niwa, H Goto, Y Majima, I Ishiguro.   

Abstract

We attempted to clarify the pattern of cataract development in 12-month-old rats fed a 25% galactose diet and to assess the relation of cataract development with osmotic stress and oxidative damage. In lenses of 12-month-old male Wistar rats fed a 25% galactose diet over an 8-month period, suture accentuation appeared at 6 months of galactose feeding and then opacities developed from the anterior subcapsular cortex toward the posterior subcapsular cortex, reaching the nuclear region at 8 months of galactose feeding. Increases in lens galactitol and lipid peroxide contents and a decrease in lens reduced glutathione content occurred at 4, 6 and 8 months of galactose feeding. The increase in lens lipid peroxide content and the decrease in lens reduced glutathione content were accelerated with an increase in feeding period, while the increase in lens galactitol content was decelerated. An increase in lens water content and a decrease in lens protein content occurred at 6 and 8 months of galactose feeding. The lens vitamin E content increased at 6 months of galactose feeding and this increase was concomitant with increases in serum vitamin E and total cholesterol concentrations. The serum lipid peroxide concentration increased at 4 and 6 months of galactose feeding. The present results indicate that in lenses of 12-month-old rats fed a 25% galactose diet, suture accentuation appears initially and then opacities develop from the anterior subcapsular cortex toward the posterior subcapsular cortex, finally reaching the nuclear region. These results also suggest that in the galactosemic aged rats, osmotic stress would mainly contribute to cataract formation, while oxidative damage could be linked to both cataract formation and progression, although an increase in lens vitamin E content occurs during the cataract development.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10420116     DOI: 10.1159/000055554

Source DB:  PubMed          Journal:  Ophthalmic Res        ISSN: 0030-3747            Impact factor:   2.892


  6 in total

1.  Theoretical considerations regarding the study "Alpha-B crystallin gene (CRYAB) mutation causes dominant congenital posterior polar cataract in humans".

Authors:  Siiri Veromann
Journal:  Am J Hum Genet       Date:  2002-09       Impact factor: 11.025

2.  Influence of galactose cataract on erythrocytic and lenticular glutathione metabolism in albino rats.

Authors:  M Jyothi; R Sanil; S Shashidhar
Journal:  Indian J Ophthalmol       Date:  2011 Jul-Aug       Impact factor: 1.848

3.  Investigation of synergistic mechanism and identification of interaction site of aldose reductase with the combination of gigantol and syringic acid for prevention of diabetic cataract.

Authors:  Jie Wu; Xue Li; Hua Fang; Yanqun Yi; Dan Chen; Yan Long; Xinxin Gao; Xiaoyong Wei; C-Y Oliver Chen
Journal:  BMC Complement Altern Med       Date:  2016-08-12       Impact factor: 3.659

4.  Selenoprotein R Protects Human Lens Epithelial Cells against D-Galactose-Induced Apoptosis by Regulating Oxidative Stress and Endoplasmic Reticulum Stress.

Authors:  Jie Dai; Hongmei Liu; Jun Zhou; Kaixun Huang
Journal:  Int J Mol Sci       Date:  2016-02-10       Impact factor: 5.923

5.  Effects of topically applied tocotrienol on cataractogenesis and lens redox status in galactosemic rats.

Authors:  Nurul Alimah Abdul Nasir; Renu Agarwal; Sushil Vasudevan; Minaketan Tripathy; Renad Alyautdin; Nafeeza Mohd Ismail
Journal:  Mol Vis       Date:  2014-06-12       Impact factor: 2.367

6.  Mechanism of the anticataract effect of liposomal MgT in galactose-fed rats.

Authors:  Igor Iezhitsa; Renu Agarwal; Sarah Diyana Bt Saad; Fatin Kamilah Bt Zakaria; Puneet Agarwal; Anna Krasilnikova; Thuhairah Hasrah Abdul Rahman; Khairul Nizam Bin Rozali; Alexander Spasov; Alexander Ozerov; Renad Alyautdin; Nafeeza Mohd Ismail
Journal:  Mol Vis       Date:  2016-07-10       Impact factor: 2.367

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.